Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
9,220
archived clinical trials in
HIV / AIDS

Atorvastatin on Biomarkers of Inflammation, Coagulopathy, Angiogenesis & T-cells
A Pilot Study Evaluating the Effect of Atorvastatin on Biomarkers of Inflammation, Coagulopathy, Angiogenesis, and T-lymphocyte Activation in HIV-1 Infected Individuals With Suppressed HIV-1 RNA and LDL Cholesterol < 130 mg/dL
Status: Enrolling
Updated:  11/10/2015
University of Washington AIDS CRS (1401)
mi
from
Seattle, WA
Atorvastatin on Biomarkers of Inflammation, Coagulopathy, Angiogenesis & T-cells
A Pilot Study Evaluating the Effect of Atorvastatin on Biomarkers of Inflammation, Coagulopathy, Angiogenesis, and T-lymphocyte Activation in HIV-1 Infected Individuals With Suppressed HIV-1 RNA and LDL Cholesterol < 130 mg/dL
Status: Enrolling
Updated: 11/10/2015
University of Washington AIDS CRS (1401)
mi
from
Seattle, WA
Click here to add this to my saved trials
Atorvastatin on Biomarkers of Inflammation, Coagulopathy, Angiogenesis & T-cells
A Pilot Study Evaluating the Effect of Atorvastatin on Biomarkers of Inflammation, Coagulopathy, Angiogenesis, and T-lymphocyte Activation in HIV-1 Infected Individuals With Suppressed HIV-1 RNA and LDL Cholesterol < 130 mg/dL
Status: Enrolling
Updated:  11/10/2015
31788 Alabama CRS
mi
from
Birmingham, AL
Atorvastatin on Biomarkers of Inflammation, Coagulopathy, Angiogenesis & T-cells
A Pilot Study Evaluating the Effect of Atorvastatin on Biomarkers of Inflammation, Coagulopathy, Angiogenesis, and T-lymphocyte Activation in HIV-1 Infected Individuals With Suppressed HIV-1 RNA and LDL Cholesterol < 130 mg/dL
Status: Enrolling
Updated: 11/10/2015
31788 Alabama CRS
mi
from
Birmingham, AL
Click here to add this to my saved trials
Atorvastatin on Biomarkers of Inflammation, Coagulopathy, Angiogenesis & T-cells
A Pilot Study Evaluating the Effect of Atorvastatin on Biomarkers of Inflammation, Coagulopathy, Angiogenesis, and T-lymphocyte Activation in HIV-1 Infected Individuals With Suppressed HIV-1 RNA and LDL Cholesterol < 130 mg/dL
Status: Enrolling
Updated:  11/10/2015
Wayne State Univ. CRS (31478)
mi
from
Detroit, MI
Atorvastatin on Biomarkers of Inflammation, Coagulopathy, Angiogenesis & T-cells
A Pilot Study Evaluating the Effect of Atorvastatin on Biomarkers of Inflammation, Coagulopathy, Angiogenesis, and T-lymphocyte Activation in HIV-1 Infected Individuals With Suppressed HIV-1 RNA and LDL Cholesterol < 130 mg/dL
Status: Enrolling
Updated: 11/10/2015
Wayne State Univ. CRS (31478)
mi
from
Detroit, MI
Click here to add this to my saved trials
Atorvastatin on Biomarkers of Inflammation, Coagulopathy, Angiogenesis & T-cells
A Pilot Study Evaluating the Effect of Atorvastatin on Biomarkers of Inflammation, Coagulopathy, Angiogenesis, and T-lymphocyte Activation in HIV-1 Infected Individuals With Suppressed HIV-1 RNA and LDL Cholesterol < 130 mg/dL
Status: Enrolling
Updated:  11/10/2015
New Jersey Medical School-Adult Clinical Research Ctr. CRS (31486)
mi
from
Newark, NJ
Atorvastatin on Biomarkers of Inflammation, Coagulopathy, Angiogenesis & T-cells
A Pilot Study Evaluating the Effect of Atorvastatin on Biomarkers of Inflammation, Coagulopathy, Angiogenesis, and T-lymphocyte Activation in HIV-1 Infected Individuals With Suppressed HIV-1 RNA and LDL Cholesterol < 130 mg/dL
Status: Enrolling
Updated: 11/10/2015
New Jersey Medical School-Adult Clinical Research Ctr. CRS (31486)
mi
from
Newark, NJ
Click here to add this to my saved trials
Atorvastatin on Biomarkers of Inflammation, Coagulopathy, Angiogenesis & T-cells
A Pilot Study Evaluating the Effect of Atorvastatin on Biomarkers of Inflammation, Coagulopathy, Angiogenesis, and T-lymphocyte Activation in HIV-1 Infected Individuals With Suppressed HIV-1 RNA and LDL Cholesterol < 130 mg/dL
Status: Enrolling
Updated:  11/10/2015
AIDS Care CRS (1101)
mi
from
Rochester, NY
Atorvastatin on Biomarkers of Inflammation, Coagulopathy, Angiogenesis & T-cells
A Pilot Study Evaluating the Effect of Atorvastatin on Biomarkers of Inflammation, Coagulopathy, Angiogenesis, and T-lymphocyte Activation in HIV-1 Infected Individuals With Suppressed HIV-1 RNA and LDL Cholesterol < 130 mg/dL
Status: Enrolling
Updated: 11/10/2015
AIDS Care CRS (1101)
mi
from
Rochester, NY
Click here to add this to my saved trials
Atorvastatin on Biomarkers of Inflammation, Coagulopathy, Angiogenesis & T-cells
A Pilot Study Evaluating the Effect of Atorvastatin on Biomarkers of Inflammation, Coagulopathy, Angiogenesis, and T-lymphocyte Activation in HIV-1 Infected Individuals With Suppressed HIV-1 RNA and LDL Cholesterol < 130 mg/dL
Status: Enrolling
Updated:  11/10/2015
University of Rochester Adult HIV Therapeutic Strategies Network CRS (31787)
mi
from
Rochester, NY
Atorvastatin on Biomarkers of Inflammation, Coagulopathy, Angiogenesis & T-cells
A Pilot Study Evaluating the Effect of Atorvastatin on Biomarkers of Inflammation, Coagulopathy, Angiogenesis, and T-lymphocyte Activation in HIV-1 Infected Individuals With Suppressed HIV-1 RNA and LDL Cholesterol < 130 mg/dL
Status: Enrolling
Updated: 11/10/2015
University of Rochester Adult HIV Therapeutic Strategies Network CRS (31787)
mi
from
Rochester, NY
Click here to add this to my saved trials
Atorvastatin on Biomarkers of Inflammation, Coagulopathy, Angiogenesis & T-cells
A Pilot Study Evaluating the Effect of Atorvastatin on Biomarkers of Inflammation, Coagulopathy, Angiogenesis, and T-lymphocyte Activation in HIV-1 Infected Individuals With Suppressed HIV-1 RNA and LDL Cholesterol < 130 mg/dL
Status: Enrolling
Updated:  11/10/2015
The Ohio State Univ. AIDS CRS (2301)
mi
from
Columbus, OH
Atorvastatin on Biomarkers of Inflammation, Coagulopathy, Angiogenesis & T-cells
A Pilot Study Evaluating the Effect of Atorvastatin on Biomarkers of Inflammation, Coagulopathy, Angiogenesis, and T-lymphocyte Activation in HIV-1 Infected Individuals With Suppressed HIV-1 RNA and LDL Cholesterol < 130 mg/dL
Status: Enrolling
Updated: 11/10/2015
The Ohio State Univ. AIDS CRS (2301)
mi
from
Columbus, OH
Click here to add this to my saved trials
Atorvastatin on Biomarkers of Inflammation, Coagulopathy, Angiogenesis & T-cells
A Pilot Study Evaluating the Effect of Atorvastatin on Biomarkers of Inflammation, Coagulopathy, Angiogenesis, and T-lymphocyte Activation in HIV-1 Infected Individuals With Suppressed HIV-1 RNA and LDL Cholesterol < 130 mg/dL
Status: Enrolling
Updated:  11/10/2015
Puerto Rico-AIDS CRS (5401)
mi
from
San Juan,
Atorvastatin on Biomarkers of Inflammation, Coagulopathy, Angiogenesis & T-cells
A Pilot Study Evaluating the Effect of Atorvastatin on Biomarkers of Inflammation, Coagulopathy, Angiogenesis, and T-lymphocyte Activation in HIV-1 Infected Individuals With Suppressed HIV-1 RNA and LDL Cholesterol < 130 mg/dL
Status: Enrolling
Updated: 11/10/2015
Puerto Rico-AIDS CRS (5401)
mi
from
San Juan,
Click here to add this to my saved trials
Cell Phone Technology Targeting ART Adherence and Drug Use
Cell Phone Technology Targeting ART Adherence and Drug Use
Status: Enrolling
Updated:  11/10/2015
UCLA Isap Ocrc
mi
from
Los Angeles, CA
Cell Phone Technology Targeting ART Adherence and Drug Use
Cell Phone Technology Targeting ART Adherence and Drug Use
Status: Enrolling
Updated: 11/10/2015
UCLA Isap Ocrc
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Cell Phone Technology Targeting ART Adherence and Drug Use
Cell Phone Technology Targeting ART Adherence and Drug Use
Status: Enrolling
Updated:  11/10/2015
UCLA ISAP Outpatient Clinical Research Center
mi
from
Los Angeles, CA
Cell Phone Technology Targeting ART Adherence and Drug Use
Cell Phone Technology Targeting ART Adherence and Drug Use
Status: Enrolling
Updated: 11/10/2015
UCLA ISAP Outpatient Clinical Research Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
A Phase II/III Trial of Lopinavir/Ritonavir Dosed According to the WHO Pediatric Weight Band Dosing Guidelines
A Phase II/III Trial of Lopinavir/Ritonavir Dosed According to the WHO Pediatric Weight Band Dosing Guidelines
Status: Enrolling
Updated:  11/16/2015
Boston Medical Center Ped. HIV Program NICHD CRS
mi
from
Boston, MA
A Phase II/III Trial of Lopinavir/Ritonavir Dosed According to the WHO Pediatric Weight Band Dosing Guidelines
A Phase II/III Trial of Lopinavir/Ritonavir Dosed According to the WHO Pediatric Weight Band Dosing Guidelines
Status: Enrolling
Updated: 11/16/2015
Boston Medical Center Ped. HIV Program NICHD CRS
mi
from
Boston, MA
Click here to add this to my saved trials
A Phase II/III Trial of Lopinavir/Ritonavir Dosed According to the WHO Pediatric Weight Band Dosing Guidelines
A Phase II/III Trial of Lopinavir/Ritonavir Dosed According to the WHO Pediatric Weight Band Dosing Guidelines
Status: Enrolling
Updated:  11/16/2015
University of California, UC San Diego CRS
mi
from
La Jolla, CA
A Phase II/III Trial of Lopinavir/Ritonavir Dosed According to the WHO Pediatric Weight Band Dosing Guidelines
A Phase II/III Trial of Lopinavir/Ritonavir Dosed According to the WHO Pediatric Weight Band Dosing Guidelines
Status: Enrolling
Updated: 11/16/2015
University of California, UC San Diego CRS
mi
from
La Jolla, CA
Click here to add this to my saved trials
A Phase II/III Trial of Lopinavir/Ritonavir Dosed According to the WHO Pediatric Weight Band Dosing Guidelines
A Phase II/III Trial of Lopinavir/Ritonavir Dosed According to the WHO Pediatric Weight Band Dosing Guidelines
Status: Enrolling
Updated:  11/16/2015
Univ. of Colorado Denver NICHD CRS
mi
from
Aurora, CO
A Phase II/III Trial of Lopinavir/Ritonavir Dosed According to the WHO Pediatric Weight Band Dosing Guidelines
A Phase II/III Trial of Lopinavir/Ritonavir Dosed According to the WHO Pediatric Weight Band Dosing Guidelines
Status: Enrolling
Updated: 11/16/2015
Univ. of Colorado Denver NICHD CRS
mi
from
Aurora, CO
Click here to add this to my saved trials
A Phase II/III Trial of Lopinavir/Ritonavir Dosed According to the WHO Pediatric Weight Band Dosing Guidelines
A Phase II/III Trial of Lopinavir/Ritonavir Dosed According to the WHO Pediatric Weight Band Dosing Guidelines
Status: Enrolling
Updated:  11/16/2015
SOM Federal University Minas Gerais Brazil NICHD CRS
mi
from
Belo Horizonte,
A Phase II/III Trial of Lopinavir/Ritonavir Dosed According to the WHO Pediatric Weight Band Dosing Guidelines
A Phase II/III Trial of Lopinavir/Ritonavir Dosed According to the WHO Pediatric Weight Band Dosing Guidelines
Status: Enrolling
Updated: 11/16/2015
SOM Federal University Minas Gerais Brazil NICHD CRS
mi
from
Belo Horizonte,
Click here to add this to my saved trials
PRO 140 by IV Administration in Adults With HIV-1 Infection
A Phase 2a, Randomized, Double-Blind, Placebo-Controlled Study of PRO 140 by Intravenous Administration in Adult Subjects With Human Immunodeficiency Virus Type 1 Infection
Status: Enrolling
Updated:  11/16/2015
Progenics Pharmaceuticals, Inc.
mi
from
Tarrytown, NY
PRO 140 by IV Administration in Adults With HIV-1 Infection
A Phase 2a, Randomized, Double-Blind, Placebo-Controlled Study of PRO 140 by Intravenous Administration in Adult Subjects With Human Immunodeficiency Virus Type 1 Infection
Status: Enrolling
Updated: 11/16/2015
Progenics Pharmaceuticals, Inc.
mi
from
Tarrytown, NY
Click here to add this to my saved trials
Anal HPV Infection and Abnormal Cytology in HIV-infected Women
Anal HPV Infection and Abnormal Cytology in HIV-infected Women
Status: Enrolling
Updated:  11/16/2015
Boston Med Ctr
mi
from
Boston, MA
Anal HPV Infection and Abnormal Cytology in HIV-infected Women
Anal HPV Infection and Abnormal Cytology in HIV-infected Women
Status: Enrolling
Updated: 11/16/2015
Boston Med Ctr
mi
from
Boston, MA
Click here to add this to my saved trials
A Phase 2a Study of Simtuzumab in HIV and/or Hepatitis C- Infected Subjects With Liver Fibrosis
A Phase 2a Study of an Anti-LOXL2 Monoclonal Antibody (GS-6624) in HIV and/or Hepatitis C- Infected Subjects With Liver Fibrosis
Status: Enrolling
Updated:  11/17/2015
NIH Department of Laboratory Medicine
mi
from
Bethesda, MD
A Phase 2a Study of Simtuzumab in HIV and/or Hepatitis C- Infected Subjects With Liver Fibrosis
A Phase 2a Study of an Anti-LOXL2 Monoclonal Antibody (GS-6624) in HIV and/or Hepatitis C- Infected Subjects With Liver Fibrosis
Status: Enrolling
Updated: 11/17/2015
NIH Department of Laboratory Medicine
mi
from
Bethesda, MD
Click here to add this to my saved trials
Boston Alcohol Research Collaboration on HIV/AIDS (ARCH) Cohort
Addressing Alcohol/HIV Consequences in Substance Dependence - Boston ARCH Cohort
Status: Enrolling
Updated:  11/17/2015
Boston Med Ctr
mi
from
Boston, MA
Boston Alcohol Research Collaboration on HIV/AIDS (ARCH) Cohort
Addressing Alcohol/HIV Consequences in Substance Dependence - Boston ARCH Cohort
Status: Enrolling
Updated: 11/17/2015
Boston Med Ctr
mi
from
Boston, MA
Click here to add this to my saved trials
Pharmacokinetic Interactions Between DMPA and LPV/r Among HIV-Infected Women
An Open-Label, Non-Randomized Study of Pharmacokinetic Interactions Between Depo-Medroxyprogesterone Acetate (DMPA) and Lopinavir/Ritonavir (LPV/r) and of the Effects of DMPA on Cellular Immunity and Regulation in HIV-Infected Women
Status: Enrolling
Updated:  11/18/2015
University of Southern California LA (5048)
mi
from
Los Angeles, CA
Pharmacokinetic Interactions Between DMPA and LPV/r Among HIV-Infected Women
An Open-Label, Non-Randomized Study of Pharmacokinetic Interactions Between Depo-Medroxyprogesterone Acetate (DMPA) and Lopinavir/Ritonavir (LPV/r) and of the Effects of DMPA on Cellular Immunity and Regulation in HIV-Infected Women
Status: Enrolling
Updated: 11/18/2015
University of Southern California LA (5048)
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Pharmacokinetic Interactions Between DMPA and LPV/r Among HIV-Infected Women
An Open-Label, Non-Randomized Study of Pharmacokinetic Interactions Between Depo-Medroxyprogesterone Acetate (DMPA) and Lopinavir/Ritonavir (LPV/r) and of the Effects of DMPA on Cellular Immunity and Regulation in HIV-Infected Women
Status: Enrolling
Updated:  11/18/2015
Washington Hospital Center NICHD CRS (5023)
mi
from
Washington,
Pharmacokinetic Interactions Between DMPA and LPV/r Among HIV-Infected Women
An Open-Label, Non-Randomized Study of Pharmacokinetic Interactions Between Depo-Medroxyprogesterone Acetate (DMPA) and Lopinavir/Ritonavir (LPV/r) and of the Effects of DMPA on Cellular Immunity and Regulation in HIV-Infected Women
Status: Enrolling
Updated: 11/18/2015
Washington Hospital Center NICHD CRS (5023)
mi
from
Washington,
Click here to add this to my saved trials
Pharmacokinetic Interactions Between DMPA and LPV/r Among HIV-Infected Women
An Open-Label, Non-Randomized Study of Pharmacokinetic Interactions Between Depo-Medroxyprogesterone Acetate (DMPA) and Lopinavir/Ritonavir (LPV/r) and of the Effects of DMPA on Cellular Immunity and Regulation in HIV-Infected Women
Status: Enrolling
Updated:  11/18/2015
South Florida Childrens Diagnostic & Treatment Cen (5055)
mi
from
Ft. Lauderdale, FL
Pharmacokinetic Interactions Between DMPA and LPV/r Among HIV-Infected Women
An Open-Label, Non-Randomized Study of Pharmacokinetic Interactions Between Depo-Medroxyprogesterone Acetate (DMPA) and Lopinavir/Ritonavir (LPV/r) and of the Effects of DMPA on Cellular Immunity and Regulation in HIV-Infected Women
Status: Enrolling
Updated: 11/18/2015
South Florida Childrens Diagnostic & Treatment Cen (5055)
mi
from
Ft. Lauderdale, FL
Click here to add this to my saved trials
Pharmacokinetic Interactions Between DMPA and LPV/r Among HIV-Infected Women
An Open-Label, Non-Randomized Study of Pharmacokinetic Interactions Between Depo-Medroxyprogesterone Acetate (DMPA) and Lopinavir/Ritonavir (LPV/r) and of the Effects of DMPA on Cellular Immunity and Regulation in HIV-Infected Women
Status: Enrolling
Updated:  11/18/2015
Northwestern University CRS (2701)
mi
from
Chicago, IL
Pharmacokinetic Interactions Between DMPA and LPV/r Among HIV-Infected Women
An Open-Label, Non-Randomized Study of Pharmacokinetic Interactions Between Depo-Medroxyprogesterone Acetate (DMPA) and Lopinavir/Ritonavir (LPV/r) and of the Effects of DMPA on Cellular Immunity and Regulation in HIV-Infected Women
Status: Enrolling
Updated: 11/18/2015
Northwestern University CRS (2701)
mi
from
Chicago, IL
Click here to add this to my saved trials
Pharmacokinetic Interactions Between DMPA and LPV/r Among HIV-Infected Women
An Open-Label, Non-Randomized Study of Pharmacokinetic Interactions Between Depo-Medroxyprogesterone Acetate (DMPA) and Lopinavir/Ritonavir (LPV/r) and of the Effects of DMPA on Cellular Immunity and Regulation in HIV-Infected Women
Status: Enrolling
Updated:  11/18/2015
Rush University Cook County Hospital Chicago NICHD CRS (5083)
mi
from
Chicago, IL
Pharmacokinetic Interactions Between DMPA and LPV/r Among HIV-Infected Women
An Open-Label, Non-Randomized Study of Pharmacokinetic Interactions Between Depo-Medroxyprogesterone Acetate (DMPA) and Lopinavir/Ritonavir (LPV/r) and of the Effects of DMPA on Cellular Immunity and Regulation in HIV-Infected Women
Status: Enrolling
Updated: 11/18/2015
Rush University Cook County Hospital Chicago NICHD CRS (5083)
mi
from
Chicago, IL
Click here to add this to my saved trials
Pharmacokinetic Interactions Between DMPA and LPV/r Among HIV-Infected Women
An Open-Label, Non-Randomized Study of Pharmacokinetic Interactions Between Depo-Medroxyprogesterone Acetate (DMPA) and Lopinavir/Ritonavir (LPV/r) and of the Effects of DMPA on Cellular Immunity and Regulation in HIV-Infected Women
Status: Enrolling
Updated:  11/18/2015
University of Rochester ACTG CRS (1101)
mi
from
Rochester, NY
Pharmacokinetic Interactions Between DMPA and LPV/r Among HIV-Infected Women
An Open-Label, Non-Randomized Study of Pharmacokinetic Interactions Between Depo-Medroxyprogesterone Acetate (DMPA) and Lopinavir/Ritonavir (LPV/r) and of the Effects of DMPA on Cellular Immunity and Regulation in HIV-Infected Women
Status: Enrolling
Updated: 11/18/2015
University of Rochester ACTG CRS (1101)
mi
from
Rochester, NY
Click here to add this to my saved trials
Pharmacokinetic Interactions Between DMPA and LPV/r Among HIV-Infected Women
An Open-Label, Non-Randomized Study of Pharmacokinetic Interactions Between Depo-Medroxyprogesterone Acetate (DMPA) and Lopinavir/Ritonavir (LPV/r) and of the Effects of DMPA on Cellular Immunity and Regulation in HIV-Infected Women
Status: Enrolling
Updated:  11/18/2015
SUNY Stony Brook NICHD CRS (5040)
mi
from
Stony Brook, NY
Pharmacokinetic Interactions Between DMPA and LPV/r Among HIV-Infected Women
An Open-Label, Non-Randomized Study of Pharmacokinetic Interactions Between Depo-Medroxyprogesterone Acetate (DMPA) and Lopinavir/Ritonavir (LPV/r) and of the Effects of DMPA on Cellular Immunity and Regulation in HIV-Infected Women
Status: Enrolling
Updated: 11/18/2015
SUNY Stony Brook NICHD CRS (5040)
mi
from
Stony Brook, NY
Click here to add this to my saved trials
Pharmacokinetic Interactions Between DMPA and LPV/r Among HIV-Infected Women
An Open-Label, Non-Randomized Study of Pharmacokinetic Interactions Between Depo-Medroxyprogesterone Acetate (DMPA) and Lopinavir/Ritonavir (LPV/r) and of the Effects of DMPA on Cellular Immunity and Regulation in HIV-Infected Women
Status: Enrolling
Updated:  11/18/2015
Unc Aids Crs
mi
from
Chapel Hill, NC
Pharmacokinetic Interactions Between DMPA and LPV/r Among HIV-Infected Women
An Open-Label, Non-Randomized Study of Pharmacokinetic Interactions Between Depo-Medroxyprogesterone Acetate (DMPA) and Lopinavir/Ritonavir (LPV/r) and of the Effects of DMPA on Cellular Immunity and Regulation in HIV-Infected Women
Status: Enrolling
Updated: 11/18/2015
Unc Aids Crs
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Pharmacokinetic Interactions Between DMPA and LPV/r Among HIV-Infected Women
An Open-Label, Non-Randomized Study of Pharmacokinetic Interactions Between Depo-Medroxyprogesterone Acetate (DMPA) and Lopinavir/Ritonavir (LPV/r) and of the Effects of DMPA on Cellular Immunity and Regulation in HIV-Infected Women
Status: Enrolling
Updated:  11/18/2015
Univ. of Cincinnati CRS (2401)
mi
from
Cincinnati, OH
Pharmacokinetic Interactions Between DMPA and LPV/r Among HIV-Infected Women
An Open-Label, Non-Randomized Study of Pharmacokinetic Interactions Between Depo-Medroxyprogesterone Acetate (DMPA) and Lopinavir/Ritonavir (LPV/r) and of the Effects of DMPA on Cellular Immunity and Regulation in HIV-Infected Women
Status: Enrolling
Updated: 11/18/2015
Univ. of Cincinnati CRS (2401)
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Pharmacokinetic Interactions Between DMPA and LPV/r Among HIV-Infected Women
An Open-Label, Non-Randomized Study of Pharmacokinetic Interactions Between Depo-Medroxyprogesterone Acetate (DMPA) and Lopinavir/Ritonavir (LPV/r) and of the Effects of DMPA on Cellular Immunity and Regulation in HIV-Infected Women
Status: Enrolling
Updated:  11/18/2015
Univ. of Cincinnati CRS
mi
from
Cincinnati, OH
Pharmacokinetic Interactions Between DMPA and LPV/r Among HIV-Infected Women
An Open-Label, Non-Randomized Study of Pharmacokinetic Interactions Between Depo-Medroxyprogesterone Acetate (DMPA) and Lopinavir/Ritonavir (LPV/r) and of the Effects of DMPA on Cellular Immunity and Regulation in HIV-Infected Women
Status: Enrolling
Updated: 11/18/2015
Univ. of Cincinnati CRS
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Pharmacokinetic Interactions Between DMPA and LPV/r Among HIV-Infected Women
An Open-Label, Non-Randomized Study of Pharmacokinetic Interactions Between Depo-Medroxyprogesterone Acetate (DMPA) and Lopinavir/Ritonavir (LPV/r) and of the Effects of DMPA on Cellular Immunity and Regulation in HIV-Infected Women
Status: Enrolling
Updated:  11/18/2015
Children's National Medical Center Washington DC NICHD CRS (5015)
mi
from
Washington,
Pharmacokinetic Interactions Between DMPA and LPV/r Among HIV-Infected Women
An Open-Label, Non-Randomized Study of Pharmacokinetic Interactions Between Depo-Medroxyprogesterone Acetate (DMPA) and Lopinavir/Ritonavir (LPV/r) and of the Effects of DMPA on Cellular Immunity and Regulation in HIV-Infected Women
Status: Enrolling
Updated: 11/18/2015
Children's National Medical Center Washington DC NICHD CRS (5015)
mi
from
Washington,
Click here to add this to my saved trials
Pharmacokinetic Interactions Between DMPA and LPV/r Among HIV-Infected Women
An Open-Label, Non-Randomized Study of Pharmacokinetic Interactions Between Depo-Medroxyprogesterone Acetate (DMPA) and Lopinavir/Ritonavir (LPV/r) and of the Effects of DMPA on Cellular Immunity and Regulation in HIV-Infected Women
Status: Enrolling
Updated:  11/18/2015
Tulane University New Orleans NICHD CRS (5095)
mi
from
New Orleans, LA
Pharmacokinetic Interactions Between DMPA and LPV/r Among HIV-Infected Women
An Open-Label, Non-Randomized Study of Pharmacokinetic Interactions Between Depo-Medroxyprogesterone Acetate (DMPA) and Lopinavir/Ritonavir (LPV/r) and of the Effects of DMPA on Cellular Immunity and Regulation in HIV-Infected Women
Status: Enrolling
Updated: 11/18/2015
Tulane University New Orleans NICHD CRS (5095)
mi
from
New Orleans, LA
Click here to add this to my saved trials
Pharmacokinetic Interactions Between DMPA and LPV/r Among HIV-Infected Women
An Open-Label, Non-Randomized Study of Pharmacokinetic Interactions Between Depo-Medroxyprogesterone Acetate (DMPA) and Lopinavir/Ritonavir (LPV/r) and of the Effects of DMPA on Cellular Immunity and Regulation in HIV-Infected Women
Status: Enrolling
Updated:  11/18/2015
University of Washington AIDS CRS (1401)
mi
from
Seattle, WA
Pharmacokinetic Interactions Between DMPA and LPV/r Among HIV-Infected Women
An Open-Label, Non-Randomized Study of Pharmacokinetic Interactions Between Depo-Medroxyprogesterone Acetate (DMPA) and Lopinavir/Ritonavir (LPV/r) and of the Effects of DMPA on Cellular Immunity and Regulation in HIV-Infected Women
Status: Enrolling
Updated: 11/18/2015
University of Washington AIDS CRS (1401)
mi
from
Seattle, WA
Click here to add this to my saved trials
Pharmacokinetic Interactions Between DMPA and LPV/r Among HIV-Infected Women
An Open-Label, Non-Randomized Study of Pharmacokinetic Interactions Between Depo-Medroxyprogesterone Acetate (DMPA) and Lopinavir/Ritonavir (LPV/r) and of the Effects of DMPA on Cellular Immunity and Regulation in HIV-Infected Women
Status: Enrolling
Updated:  11/18/2015
San Juan Hospital PR NICHD CRS (5031)
mi
from
San Juan,
Pharmacokinetic Interactions Between DMPA and LPV/r Among HIV-Infected Women
An Open-Label, Non-Randomized Study of Pharmacokinetic Interactions Between Depo-Medroxyprogesterone Acetate (DMPA) and Lopinavir/Ritonavir (LPV/r) and of the Effects of DMPA on Cellular Immunity and Regulation in HIV-Infected Women
Status: Enrolling
Updated: 11/18/2015
San Juan Hospital PR NICHD CRS (5031)
mi
from
San Juan,
Click here to add this to my saved trials
Trial of the Safety and Immunogenicity of an Oral, Replicating Ad26 Vectored HIV-1 Vaccine
A Phase 1 Clinical Trial of the Safety and Immunogenicity of an Oral, Replicating Adenovirus 26 Vector Vaccine for HIV-1 (rcAd26.MOS1.HIV-Env) in Healthy HIV-1-uninfected Adults
Status: Enrolling
Updated:  11/18/2015
University of Rochester
mi
from
Rochester, NY
Trial of the Safety and Immunogenicity of an Oral, Replicating Ad26 Vectored HIV-1 Vaccine
A Phase 1 Clinical Trial of the Safety and Immunogenicity of an Oral, Replicating Adenovirus 26 Vector Vaccine for HIV-1 (rcAd26.MOS1.HIV-Env) in Healthy HIV-1-uninfected Adults
Status: Enrolling
Updated: 11/18/2015
University of Rochester
mi
from
Rochester, NY
Click here to add this to my saved trials
Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults
A Phase 3b, Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir Plus Two Fully Active Nucleoside Reverse Transcriptase Inhibitors in HIV-1 Infected, Antiretroviral Treatment-Naïve and -Experienced Adults With No Darunavir Resistance-associated Mutations
Status: Enrolling
Updated:  11/20/2015
Spectrum Medical Group
mi
from
Phoenix, AZ
Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults
A Phase 3b, Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir Plus Two Fully Active Nucleoside Reverse Transcriptase Inhibitors in HIV-1 Infected, Antiretroviral Treatment-Naïve and -Experienced Adults With No Darunavir Resistance-associated Mutations
Status: Enrolling
Updated: 11/20/2015
Spectrum Medical Group
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults
A Phase 3b, Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir Plus Two Fully Active Nucleoside Reverse Transcriptase Inhibitors in HIV-1 Infected, Antiretroviral Treatment-Naïve and -Experienced Adults With No Darunavir Resistance-associated Mutations
Status: Enrolling
Updated:  11/20/2015
Anthony Mills MD Inc
mi
from
Los Angeles, CA
Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults
A Phase 3b, Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir Plus Two Fully Active Nucleoside Reverse Transcriptase Inhibitors in HIV-1 Infected, Antiretroviral Treatment-Naïve and -Experienced Adults With No Darunavir Resistance-associated Mutations
Status: Enrolling
Updated: 11/20/2015
Anthony Mills MD Inc
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults
A Phase 3b, Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir Plus Two Fully Active Nucleoside Reverse Transcriptase Inhibitors in HIV-1 Infected, Antiretroviral Treatment-Naïve and -Experienced Adults With No Darunavir Resistance-associated Mutations
Status: Enrolling
Updated:  11/20/2015
Peter J. Ruane, MD, Inc.
mi
from
Los Angeles, CA
Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults
A Phase 3b, Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir Plus Two Fully Active Nucleoside Reverse Transcriptase Inhibitors in HIV-1 Infected, Antiretroviral Treatment-Naïve and -Experienced Adults With No Darunavir Resistance-associated Mutations
Status: Enrolling
Updated: 11/20/2015
Peter J. Ruane, MD, Inc.
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults
A Phase 3b, Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir Plus Two Fully Active Nucleoside Reverse Transcriptase Inhibitors in HIV-1 Infected, Antiretroviral Treatment-Naïve and -Experienced Adults With No Darunavir Resistance-associated Mutations
Status: Enrolling
Updated:  11/20/2015
La Playa Medical Group and Clinical Research
mi
from
San Diego, CA
Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults
A Phase 3b, Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir Plus Two Fully Active Nucleoside Reverse Transcriptase Inhibitors in HIV-1 Infected, Antiretroviral Treatment-Naïve and -Experienced Adults With No Darunavir Resistance-associated Mutations
Status: Enrolling
Updated: 11/20/2015
La Playa Medical Group and Clinical Research
mi
from
San Diego, CA
Click here to add this to my saved trials
Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults
A Phase 3b, Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir Plus Two Fully Active Nucleoside Reverse Transcriptase Inhibitors in HIV-1 Infected, Antiretroviral Treatment-Naïve and -Experienced Adults With No Darunavir Resistance-associated Mutations
Status: Enrolling
Updated:  11/20/2015
Metropolis Medical
mi
from
San Francisco, CA
Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults
A Phase 3b, Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir Plus Two Fully Active Nucleoside Reverse Transcriptase Inhibitors in HIV-1 Infected, Antiretroviral Treatment-Naïve and -Experienced Adults With No Darunavir Resistance-associated Mutations
Status: Enrolling
Updated: 11/20/2015
Metropolis Medical
mi
from
San Francisco, CA
Click here to add this to my saved trials
Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults
A Phase 3b, Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir Plus Two Fully Active Nucleoside Reverse Transcriptase Inhibitors in HIV-1 Infected, Antiretroviral Treatment-Naïve and -Experienced Adults With No Darunavir Resistance-associated Mutations
Status: Enrolling
Updated:  11/20/2015
Whitman Walker Health
mi
from
Washington,
Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults
A Phase 3b, Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir Plus Two Fully Active Nucleoside Reverse Transcriptase Inhibitors in HIV-1 Infected, Antiretroviral Treatment-Naïve and -Experienced Adults With No Darunavir Resistance-associated Mutations
Status: Enrolling
Updated: 11/20/2015
Whitman Walker Health
mi
from
Washington,
Click here to add this to my saved trials
Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults
A Phase 3b, Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir Plus Two Fully Active Nucleoside Reverse Transcriptase Inhibitors in HIV-1 Infected, Antiretroviral Treatment-Naïve and -Experienced Adults With No Darunavir Resistance-associated Mutations
Status: Enrolling
Updated:  11/20/2015
Dupont Circle Physician's Group
mi
from
Washington,
Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults
A Phase 3b, Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir Plus Two Fully Active Nucleoside Reverse Transcriptase Inhibitors in HIV-1 Infected, Antiretroviral Treatment-Naïve and -Experienced Adults With No Darunavir Resistance-associated Mutations
Status: Enrolling
Updated: 11/20/2015
Dupont Circle Physician's Group
mi
from
Washington,
Click here to add this to my saved trials
Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults
A Phase 3b, Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir Plus Two Fully Active Nucleoside Reverse Transcriptase Inhibitors in HIV-1 Infected, Antiretroviral Treatment-Naïve and -Experienced Adults With No Darunavir Resistance-associated Mutations
Status: Enrolling
Updated:  11/20/2015
Gary J. Richmond, M.D., P.A.
mi
from
Fort Lauderdale, FL
Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults
A Phase 3b, Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir Plus Two Fully Active Nucleoside Reverse Transcriptase Inhibitors in HIV-1 Infected, Antiretroviral Treatment-Naïve and -Experienced Adults With No Darunavir Resistance-associated Mutations
Status: Enrolling
Updated: 11/20/2015
Gary J. Richmond, M.D., P.A.
mi
from
Fort Lauderdale, FL
Click here to add this to my saved trials
Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults
A Phase 3b, Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir Plus Two Fully Active Nucleoside Reverse Transcriptase Inhibitors in HIV-1 Infected, Antiretroviral Treatment-Naïve and -Experienced Adults With No Darunavir Resistance-associated Mutations
Status: Enrolling
Updated:  11/20/2015
Midway Immunology and Research Center
mi
from
Fort Pierce, FL
Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults
A Phase 3b, Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir Plus Two Fully Active Nucleoside Reverse Transcriptase Inhibitors in HIV-1 Infected, Antiretroviral Treatment-Naïve and -Experienced Adults With No Darunavir Resistance-associated Mutations
Status: Enrolling
Updated: 11/20/2015
Midway Immunology and Research Center
mi
from
Fort Pierce, FL
Click here to add this to my saved trials
Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults
A Phase 3b, Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir Plus Two Fully Active Nucleoside Reverse Transcriptase Inhibitors in HIV-1 Infected, Antiretroviral Treatment-Naïve and -Experienced Adults With No Darunavir Resistance-associated Mutations
Status: Enrolling
Updated:  11/20/2015
Wohlfeiler, Piperato and Associates, LLC
mi
from
Miami Beach, FL
Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults
A Phase 3b, Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir Plus Two Fully Active Nucleoside Reverse Transcriptase Inhibitors in HIV-1 Infected, Antiretroviral Treatment-Naïve and -Experienced Adults With No Darunavir Resistance-associated Mutations
Status: Enrolling
Updated: 11/20/2015
Wohlfeiler, Piperato and Associates, LLC
mi
from
Miami Beach, FL
Click here to add this to my saved trials
Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults
A Phase 3b, Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir Plus Two Fully Active Nucleoside Reverse Transcriptase Inhibitors in HIV-1 Infected, Antiretroviral Treatment-Naïve and -Experienced Adults With No Darunavir Resistance-associated Mutations
Status: Enrolling
Updated:  11/20/2015
Orlando Immunology Center
mi
from
Orlando, FL
Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults
A Phase 3b, Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir Plus Two Fully Active Nucleoside Reverse Transcriptase Inhibitors in HIV-1 Infected, Antiretroviral Treatment-Naïve and -Experienced Adults With No Darunavir Resistance-associated Mutations
Status: Enrolling
Updated: 11/20/2015
Orlando Immunology Center
mi
from
Orlando, FL
Click here to add this to my saved trials
Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults
A Phase 3b, Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir Plus Two Fully Active Nucleoside Reverse Transcriptase Inhibitors in HIV-1 Infected, Antiretroviral Treatment-Naïve and -Experienced Adults With No Darunavir Resistance-associated Mutations
Status: Enrolling
Updated:  11/20/2015
St Joseph's Comprehensive Research Institute
mi
from
Tampa, FL
Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults
A Phase 3b, Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir Plus Two Fully Active Nucleoside Reverse Transcriptase Inhibitors in HIV-1 Infected, Antiretroviral Treatment-Naïve and -Experienced Adults With No Darunavir Resistance-associated Mutations
Status: Enrolling
Updated: 11/20/2015
St Joseph's Comprehensive Research Institute
mi
from
Tampa, FL
Click here to add this to my saved trials
Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults
A Phase 3b, Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir Plus Two Fully Active Nucleoside Reverse Transcriptase Inhibitors in HIV-1 Infected, Antiretroviral Treatment-Naïve and -Experienced Adults With No Darunavir Resistance-associated Mutations
Status: Enrolling
Updated:  11/20/2015
Atlanta ID Group
mi
from
Atlanta, GA
Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults
A Phase 3b, Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir Plus Two Fully Active Nucleoside Reverse Transcriptase Inhibitors in HIV-1 Infected, Antiretroviral Treatment-Naïve and -Experienced Adults With No Darunavir Resistance-associated Mutations
Status: Enrolling
Updated: 11/20/2015
Atlanta ID Group
mi
from
Atlanta, GA
Click here to add this to my saved trials
Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults
A Phase 3b, Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir Plus Two Fully Active Nucleoside Reverse Transcriptase Inhibitors in HIV-1 Infected, Antiretroviral Treatment-Naïve and -Experienced Adults With No Darunavir Resistance-associated Mutations
Status: Enrolling
Updated:  11/20/2015
Infectious Disease Specialists of Atlanta
mi
from
Decatur, GA
Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults
A Phase 3b, Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir Plus Two Fully Active Nucleoside Reverse Transcriptase Inhibitors in HIV-1 Infected, Antiretroviral Treatment-Naïve and -Experienced Adults With No Darunavir Resistance-associated Mutations
Status: Enrolling
Updated: 11/20/2015
Infectious Disease Specialists of Atlanta
mi
from
Decatur, GA
Click here to add this to my saved trials
Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults
A Phase 3b, Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir Plus Two Fully Active Nucleoside Reverse Transcriptase Inhibitors in HIV-1 Infected, Antiretroviral Treatment-Naïve and -Experienced Adults With No Darunavir Resistance-associated Mutations
Status: Enrolling
Updated:  11/20/2015
Mercer University
mi
from
Macon, GA
Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults
A Phase 3b, Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir Plus Two Fully Active Nucleoside Reverse Transcriptase Inhibitors in HIV-1 Infected, Antiretroviral Treatment-Naïve and -Experienced Adults With No Darunavir Resistance-associated Mutations
Status: Enrolling
Updated: 11/20/2015
Mercer University
mi
from
Macon, GA
Click here to add this to my saved trials
Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults
A Phase 3b, Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir Plus Two Fully Active Nucleoside Reverse Transcriptase Inhibitors in HIV-1 Infected, Antiretroviral Treatment-Naïve and -Experienced Adults With No Darunavir Resistance-associated Mutations
Status: Enrolling
Updated:  11/20/2015
Hawaii Center for AIDS, University of Hawaii
mi
from
Honolulu, HI
Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults
A Phase 3b, Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir Plus Two Fully Active Nucleoside Reverse Transcriptase Inhibitors in HIV-1 Infected, Antiretroviral Treatment-Naïve and -Experienced Adults With No Darunavir Resistance-associated Mutations
Status: Enrolling
Updated: 11/20/2015
Hawaii Center for AIDS, University of Hawaii
mi
from
Honolulu, HI
Click here to add this to my saved trials
Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults
A Phase 3b, Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir Plus Two Fully Active Nucleoside Reverse Transcriptase Inhibitors in HIV-1 Infected, Antiretroviral Treatment-Naïve and -Experienced Adults With No Darunavir Resistance-associated Mutations
Status: Enrolling
Updated:  11/20/2015
Northstar Medical Center
mi
from
Chicago, IL
Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults
A Phase 3b, Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir Plus Two Fully Active Nucleoside Reverse Transcriptase Inhibitors in HIV-1 Infected, Antiretroviral Treatment-Naïve and -Experienced Adults With No Darunavir Resistance-associated Mutations
Status: Enrolling
Updated: 11/20/2015
Northstar Medical Center
mi
from
Chicago, IL
Click here to add this to my saved trials